25.03.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution ...

Q4 2024 Management View Walter Klemp, Chairman and CEO, announced significant progress on the MIRACLE Phase 3 pivotal trial for Annamycin, targeting second-line treatment of relapsed and refractory ...

An AML compliance consultant helps businesses spot financial risks before they become issues. These experts analyze ...

U.S.Ambassador to Liberia, Mark Toner visited ArcelorMittal Liberia operations, leaving with a positive impression about the significant investment the company has made in the county, which he ...

The Institute of Chartered Accountants of Bangladesh (ICAB) organised a webinar on ‘Evolving Role of Accountants in AML ...

Kura Oncology and Kyowa Kirin announced they entered into a global strategic collaboration to develop and commercialize ziftomenib (Kyowa Agreement), funding the expansive AML development program ...

Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...

The Government of Liberia has taken a decisive step toward implementing its multiuser rail policy by formally requesting that ...

Agreement/Incoming OrdersEckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities 25.03.2025 / 09:30 CET/CESTThe issuer is solely responsible for the ...